Cambridge Investment Research Advisors
IBDK

Cambridge Investment Research Advisors’s iShares iBonds Dec 2019 Term Corporate ETF IBDK Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBDK Stock Details IBDK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-33,465
Closed -$832K – 2519
2019
Q3 		$832K Buy
33,465
+11,734
+54% +$292K 0.01% 1181
2019
Q2 		$540K Buy
+21,731
New +$540K 0.01% 1376
2017
Q3 		– Sell
-8,871
Closed -$222K – 2108
2017
Q2 		$222K Buy
+8,871
New +$222K ﹤0.01% 1688

Other funds holding IBDK

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Cambridge Investment Research Advisors's IBDK Position: Q4 2019 in Review

Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2019 Term Corporate ETF (IBDK) in Q4 2019, closing a stake of 33,465 shares — an estimated $832K sold.

Cambridge Investment Research Advisors first reported a position in IBDK in Q2 2017 and held it in 3 quarters. The position peaked at $832K in Q3 2019. 1 fund tracked by Wall St. Rank holds IBDK as of Q4 2019.

  • Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2019 Term Corporate ETF position as of Q4 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 33,465 iShares iBonds Dec 2019 Term Corporate ETF shares in Q4 2019, an estimated $832K.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2019 Term Corporate ETF in Q2 2017 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2019 Term Corporate ETF position peaked at $832K in Q3 2019.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2019 Term Corporate ETF as of Q4 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.